Send to a Friend Font Size: Increase Decrease

INCY and PRLD Related Headlines

Nov 4, 2025 07:01AM Prelude Therapeutics secures $60M from Incyte option deal
Nov 4, 2025 07:01AM Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors

INCY and PRLD Related Press Releases

Nov 4, 2025 07:01AM Prelude Therapeutics Announces Exclusive Option Agreement with Incyte to Advance Mutant Selective JAK2V617F JH2 Inhibitors

INCY and PRLD Related SEC Filings